Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

We'd appreciate your feedback on this new experience.Tell us what you think(opens in new tab/window)

Publish with us

Conference speaker

Robin Shattock


Robin Shattock

Imperial College London, UK

Robin Shattock has over 30 years’ experience in research and development of vaccines and antiviral therapeutics. He is a Professor of Mucosal Infection and Immunity at Imperial College, London.

 His academic research portfolio includes vaccine projects on SARS-CoV2, HIV, Ebola, Lassa fever, Marburg and Rabies viruses and Chlamydia. He has a strong track record of translation research having taken a wide range of vaccine products through from discovery into clinical testing. The Shattock group was the first in the world to publish on the evaluation of a self-amplifying RNA vaccine against COVID-19 in phase I/II clinical trials. Robin leads the EPSRC Future Vaccines Manufacturing Research Hub at Imperial college. He is Founder of VaxEquity Ltd an Imperial spin-out focused on development of self-amplifying RNA. Robin is an elected fellow of the Academy of Medical Sciences.